CDK6 increases glycolysis and suppresses autophagy by mTORC1-HK2 pathway activation in cervical cancer cells

References

• Arbyn M, Weiderpass E, Bruni L, et al. Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis. Lancet Glob Health. 2020;8(2):e191–e203.
   PubMed Web of Science ®Google Scholar
• Cohen PA, Jhingran A, Oaknin A, et al. Cervical cancer. Lancet. 2019;393(10167):169–182.
   PubMed Web of Science ®Google Scholar
• Arafah M, Rashid S, Tulbah A, et al. Carcinomas of the uterine cervix: comprehensive review with an update on pathogenesis, nomenclature of precursor and invasive lesions, and differential diagnostic considerations. Adv Anat Pathol. 2021;28(3):150–170.
   PubMed Web of Science ®Google Scholar
• Meijer CJLM, Steenbergen RDM. Gynaecological cancer: novel molecular subtypes of cervical cancer - potential clinical consequences. Nat Rev Clin Oncol. 2017;14(7):397–398.
   PubMed Web of Science ®Google Scholar
• Pirog EC, Lloveras B, Molijn A, et al. HPV prevalence and genotypes in different histological subtypes of cervical adenocarcinoma, a worldwide analysis of 760 cases. Mod Pathol. 2014;27(12):1559–1567.
   PubMed Web of Science ®Google Scholar
• Stolnicu S, Hoang L, Soslow RA. Recent advances in invasive adenocarcinoma of the cervix. Virchows Arch. 2019;475(5):537–549.
   PubMed Web of Science ®Google Scholar
• Kim YT, Zhao M. Aberrant cell cycle regulation in cervical carcinoma. Yonsei Med J. 2005;46(5):597–613.
   PubMed Web of Science ®Google Scholar
• Choi YJ, Anders L. Signaling through cyclin D-dependent kinases. Oncogene. 2014;33(15):1890–1903.
   PubMed Web of Science ®Google Scholar
• Tomita T, Huibregtse JM, Matouschek A. A masked initiation region in retinoblastoma protein regulates its proteasomal degradation. Nat commun. 2020;11(1):2019.
   PubMed Web of Science ®Google Scholar
• Ohtani K, DeGregori J, Nevins JR. Regulation of the cyclin E gene by transcription factor E2F1. Proc Natl Acad Sci USA. 1995;92(26):12146–12150.
   PubMed Web of Science ®Google Scholar
• Arvanitis DA, Spandidos DA. Deregulation of the G1/S phase transition in cancer and squamous intraepithelial lesions of the uterine cervix: a case control study. Oncol Rep. 2008;20(4):751–760.
   PubMed Web of Science ®Google Scholar
• Aierken K, Dong Z, Abulimiti T, et al. CDK6 3ʹUTR polymorphisms alter the susceptibility to cervical cancer among Uyghur females. Mol Genet Genomic Med. 2019;7(5):e626.
   PubMed Web of Science ®Google Scholar
• Wang H, Nicolay BN, Chick JM, et al. The metabolic function of cyclin D3-CDK6 kinase in cancer cell survival. Nature. 2017;546(7658):426–430.
   PubMed Web of Science ®Google Scholar
• Hu QL, Xu ZP, Lan YF, et al. miR-636 represses cell survival by targeting CDK6/Bcl-2 in cervical cancer. Kaohsiung J Med Sci. 2020;36(5):328–335.
   PubMed Web of Science ®Google Scholar
• Liu Q, Liu S, Wang X, et al. LncRNA MAGI2-AS3 is involved in cervical squamous cell carcinoma development through CDK6 up-regulation. Infect Agent Cancer. 2019;14:37.
   PubMed Web of Science ®Google Scholar
• Xiong Y, Li T, Assani G, et al. Ribociclib, a selective cyclin D kinase 4/6 inhibitor, inhibits proliferation and induces apoptosis of human cervical cancer in vitro and in vivo. Biomed Pharmacother. 2019;112:108602.
   PubMed Web of Science ®Google Scholar
• Liu GY, Sabatini DM. mTOR at the nexus of nutrition, growth, ageing and disease. Nat Rev Mol Cell Biol. 2020;21(4):183–203.
   PubMed Web of Science ®Google Scholar
• Chiarini F, Evangelisti C, McCubrey JA, et al. Current treatment strategies for inhibiting mTOR in cancer. Trends Pharmacol Sci. 2015;36(2):124–135.
   PubMed Web of Science ®Google Scholar
• Romero-Pozuelo J, Figlia G, Kaya O, et al. Cdk4 and Cdk6 couple the cell-cycle machinery to cell growth via mTORC1. Cell Rep. 2020;31(2):107504.
   PubMed Web of Science ®Google Scholar
• Düvel K, Yecies JL, Menon S, et al. Activation of a metabolic gene regulatory network downstream of mTOR complex 1. Mol Cell. 2010;39(2):171–183.
   PubMed Web of Science ®Google Scholar
• Bhaskar PT, Nogueira V, Patra KC, et al. mTORC1 hyperactivity inhibits serum deprivation-induced apoptosis via increased hexokinase II and GLUT1 expression, sustained Mcl-1 expression, and glycogen synthase kinase 3beta inhibition. Mol Cell Biol. 2009;29(18):5136–5147.
   PubMed Web of Science ®Google Scholar
• Liu C, Wang X, Zhang Y. The roles of HK2 on tumorigenesis of cervical cancer. Technol Cancer Res Treat. 2019;18:1533033819871306.
   Web of Science ®Google Scholar
• Amaravadi R, Kimmelman AC, White E. Recent insights into the function of autophagy in cancer. Genes Dev. 2016;30(17):1913–1930.
   PubMed Web of Science ®Google Scholar
• Mattoscio D, Medda A, Chiocca S. Human papilloma virus and autophagy. Int J Mol Sci. 2018;19(6):1775.
   PubMed Web of Science ®Google Scholar
• Hou X, Zhang Y, Li W, et al. CDK6 inhibits white to beige fat transition by suppressing RUNX1. Nat Commun. 2018;9(1):1023.
   PubMedGoogle Scholar
• Jena N, Sheng J, Hu JK, et al. CDK6-mediated repression of CD25 is required for induction and maintenance of Notch1-induced T-cell acute lymphoblastic leukemia. Leukemia. 2016;30(5):1033–1043.
   PubMed Web of Science ®Google Scholar
• Hu MG, Deshpande A, Schlichting N, et al. CDK6 kinase activity is required for thymocyte development. Blood. 2011;117(23):6120–6131.
   PubMed Web of Science ®Google Scholar
• Schmitz ML, Kracht M. Cyclin-dependent kinases as coregulators of inflammatory gene expression. Trends Pharmacol Sci. 2016;37(2):101–113.
   PubMed Web of Science ®Google Scholar
• Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646–674.
   PubMed Web of Science ®Google Scholar
• Sivridis E, Koukourakis MI, Zois CE, et al. LC3A-positive light microscopy detected patterns of autophagy and prognosis in operable breast carcinomas. Am J Pathol. 2010;176(5):2477–2489.
   PubMed Web of Science ®Google Scholar
• Kim J, Kundu M, Viollet B, et al. AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nat Cell Biol. 2011;13(2):132–141.
   PubMed Web of Science ®Google Scholar
• Mathew R, Karp CM, Beaudoin B, et al. Autophagy suppresses tumorigenesis through elimination of p62. Cell. 2009;137(6):1062–1075.
   PubMed Web of Science ®Google Scholar
• Klionsky DJ, Abdel-Aziz AK, Abdelfatah S, et al. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition). Autophagy. 2021;17(1):1–382.
   PubMed Web of Science ®Google Scholar
• Jiao L, Zhang HL, Li DD, et al. Regulation of glycolytic metabolism by autophagy in liver cancer involves selective autophagic degradation of HK2 (hexokinase 2). Autophagy. 2018;14(4):671–684.
   PubMed Web of Science ®Google Scholar
• Liang L, Huang D, Wang H, et al. In situ surface-enhanced Raman scattering spectroscopy exploring molecular changes of drug-treated cancer cell nucleus. Anal Chem. 2015;87(4):2504–2510.
   PubMed Web of Science ®Google Scholar
• Duraipandian S, Zheng W, Ng J, et al. Near-infrared-excited confocal Raman spectroscopy advances in vivo diagnosis of cervical precancer. J Biomed Opt. 2013;18(6):067007.
   PubMed Web of Science ®Google Scholar
• Ali MR, Wu Y, Han T, et al. Simultaneous time-dependent surface-enhanced raman spectroscopy, metabolomics, and proteomics reveal cancer cell death mechanisms associated with gold nanorod photothermal therapy. J Am Chem Soc. 2016;138(47):15434–15442.
   PubMed Web of Science ®Google Scholar
• Li X, Sha J, Chu B, et al. Quantitative visualization of intracellular lipids concentration in a microalgae cell based on Raman micro-spectroscopy coupled with chemometrics. Sens Actuators B Chem. 2019;292:7–15.
   Web of Science ®Google Scholar
• Movasaghi Z, Rehman S, Rehman IU. Raman spectroscopy of biological tissues. Appl Spectrosc Rev. 2007;42:493–541.
   Web of Science ®Google Scholar
• Onogi C, Motoyama M, Hamaguchi H. High concentration trans form unsaturated lipids detected in a HeLa cell by Raman microspectroscopy. J Raman Spectrosc. 2008;39:555–556.
   Web of Science ®Google Scholar
• Brozek-Pluska B, Dziki A, Abramczyk H. Virtual spectral histopathology of colon cancer-biomedical applications of Raman spectroscopy and imaging. J Mol Liq. 2020;303:112676.
   Web of Science ®Google Scholar
• Zhang L, Fried FB, Guo H, et al. Cyclin-dependent kinase phosphorylation of RUNX1/AML1 on 3 sites increases transactivation potency and stimulates cell proliferation. Blood. 2008;111(3):1193–1200.
   PubMed Web of Science ®Google Scholar
• Lee G, Zheng Y, Cho S, et al. Post-transcriptional regulation of de novo lipogenesis by mTORC1-S6K1-SRPK2 signaling. Cell. 2017;171(7):1545–1558.
   PubMed Web of Science ®Google Scholar
• Kollmann K, Heller G, Schneckenleithner C, et al. A kinase-independent function of CDK6 links the cell cycle to tumor angiogenesis. Cancer Cell. 2013;24(2):167–181.
   PubMed Web of Science ®Google Scholar
• Bellutti F, Tigan AS, Nebenfuehr S, et al. CDK6 antagonizes p53-induced responses during tumorigenesis. Cancer Discov. 2018;8(7):884–897.
   PubMed Web of Science ®Google Scholar
• Aubrey BJ, Kelly GL, Janic A, et al. How does p53 induce apoptosis and how does this relate to p53-mediated tumour suppression? Cell Death Differ. 2018;25(1):104–113.
   PubMed Web of Science ®Google Scholar
• Robey RB, Hay N. Mitochondrial hexokinases, novel mediators of the antiapoptotic effects of growth factors and Akt. Oncogene. 2006;25(34):4683–4696.
   PubMed Web of Science ®Google Scholar
• Sun Y, Ai JZ, Jin X, et al. IL-8 protects prostate cancer cells from GSK-3β-induced oxidative stress by activating the mTOR signaling pathway. Prostate. 2019;79(10):1180–1190.
   PubMed Web of Science ®Google Scholar
• Dorrello NV, Peschiaroli A, Guardavaccaro D, et al. S6K1- and betaTRCP-mediated degradation of PDCD4 promotes protein translation and cell growth. Science. 2006;314(5798):467–471.
   PubMed Web of Science ®Google Scholar
• Casimiro MC, Di Sante G, Di Rocco A, et al. Cyclin D1 restrains oncogene-induced autophagy by regulating the AMPK-LKB1 signaling axis. Cancer Res. 2017;77(13):3391–3405.
   PubMed Web of Science ®Google Scholar
• Sumi NJ, Kuenzi BM, Knezevic CE, et al. Chemoproteomics reveals novel protein and lipid kinase targets of clinical CDK4/6 inhibitors in lung cancer. ACS Chem Biol. 2015;10(12):2680–2686.
   PubMed Web of Science ®Google Scholar
• Kim YM, Jung CH, Seo M, et al. mTORC1 phosphorylates UVRAG to negatively regulate autophagosome and endosome maturation. Mol Cell. 2015;57(2):207–218.
   PubMed Web of Science ®Google Scholar
• Oyervides-Muñoz MA, Pérez-Maya AA, Rodríguez-Gutiérrez HF, et al. Understanding the HPV integration and its progression to cervical cancer. Infect Genet Evol. 2018;61:134–144.
   PubMed Web of Science ®Google Scholar
• The Cancer Genome Atlas Reserch Network. Integrated genomic and molecular characterization of cervical cancer. Nature. 2017;543(7645):378–384.
   PubMed Web of Science ®Google Scholar
• Sun X, Fu P, Xie L, et al. Resveratrol inhibits the progression of cervical cancer by suppressing the transcription and expression of HPV E6 and E7 genes. Int J Mol Med. 2021;47(1):335–345.
   PubMed Web of Science ®Google Scholar
• Jiang P, Wang L, Hou B, et al. A novel HPV16 E7-affitoxin for targeted therapy of HPV16-induced human cervical cancer. Theranostics. 2018;8(13):3544–3558.
   PubMed Web of Science ®Google Scholar
• Akagi K, Li J, Broutian TR, et al. Genome-wide analysis of HPV integration in human cancers reveals recurrent, focal genomic instability. Genome Res. 2014;24(2):185–199.
   PubMed Web of Science ®Google Scholar
• Xu F, Cao M, Shi Q, et al. Integration of the full-length HPV16 genome in cervical cancer and Caski and Siha cell lines and the possible ways of HPV integration. Virus Genes. 2015;50(2):210–220.
   PubMed Web of Science ®Google Scholar
• Hu Z, Zhu D, Wang W, et al. Genome-wide profiling of HPV integration in cervical cancer identifies clustered genomic hot spots and a potential microhomology-mediated integration mechanism. Nat Genet. 2015;47(2):158–163.
   PubMed Web of Science ®Google Scholar
• Ouyang P, Wu K, Su L, et al. Inhibition of human cervical cancer cell invasion by IL-37 involving runt related transcription factor 2 suppression. Ann Transl Med. 2019;7(20):568.
   PubMed Web of Science ®Google Scholar
• Spangle JM, Münger K. The human papillomavirus type 16 E6 oncoprotein activates mTORC1 signaling and increases protein synthesis. J Virol. 2010;84(18):9398–9407.
   PubMed Web of Science ®Google Scholar